Values First Advisors, Inc.
Position in AXSM — Axsome Therapeutics, Inc.
CIK 1913608
JOHNSON CITY, TN
Position in AXSM
as of Jun 30, 2026
· filed Aug 4, 2026
Position Value
$812,636
+$37,342 QoQ
Shares Held
3,320
-27.6% QoQ
Ownership
0.006%
of shares outstanding
% of Portfolio
0.52%
of 13F equity value
Holder Rank
#284
of 503 holders
Holding Since
Sep 2024
8 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in AXSM Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Values First Advisors, Inc. holds $10,629,094 across 12 Biotechnology names. AXSM ranks #7 (7.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TECH |
BIO-TECHNE Corp
|
40,301 | $2,847,264 | |
| 2 | RPRX |
Royalty Pharma plc
|
21,005 | $1,177,750 | |
| 3 | MIRM |
Mirum Pharmaceuticals, Inc.
|
9,479 | $1,109,706 | |
| 4 | SRRK |
Scholar Rock Holding Corp
|
19,463 | $1,070,465 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
3,178 | $956,673 | |
| 6 | ARGX |
Argenx SE
|
999 | $926,842 | |
| 7 | AXSM |
Axsome Therapeutics, Inc.
This page
|
3,320 | $812,636 | |
| 8 | EXEL |
Exelixis, Inc.
|
14,397 | $783,340 |
All Filings in AXSM
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $812,636 | 3,320 | Shares | Sole | 2026-08-04 | |
| 2026-03-31 | $775,294 | 4,587 | Shares | Sole | 2026-04-17 | |
| 2025-12-31 | $803,981 | 4,402 | Shares | Sole | 2026-01-30 | |
| 2025-09-30 | $592,918 | 4,882 | Shares | Sole | 2025-10-21 | |
| 2025-06-30 | $533,328 | 5,109 | Shares | Sole | 2025-07-29 | |
| 2025-03-31 | $555,625 | 4,764 | Shares | Sole | 2025-04-30 | |
| 2024-12-31 | $428,972 | 5,070 | Shares | Sole | 2025-01-29 | |
| 2024-09-30 | $568,158 | 6,322 | Shares | Sole | 2024-10-23 | |
| No filing history on record for this holder in this stock. | ||||||